Rifat Pamukcu - Director at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
APRE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Rifat Pamukcu since 10 Mar 2025

Holdings reported by Rifat Pamukcu for Aprea Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 14,108 $22,854 $1.62 05 Jun 2025 By ZNZ Holdings LLC
Common Stock 5,446 $8,822 $1.62 05 Jun 2025 Direct
Stock Options (Right to Buy) 4,185 20 Jun 2024 Direct Common Stock
Stock Options (Right to Buy) 4,185 05 Jun 2025 Direct Common Stock

Transactions reported by Rifat Pamukcu for Aprea Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.